Intuitive Surgical Dominates Robotic Surgery Amid Tech Expansion and Competition

Intuitive Surgical (ISRG) continues to dominate the robotic surgery market through its da Vinci systems, leveraging a high-margin recurring revenue model from instruments and services. The company is aggressively expanding into new surgical specialties and integrating Artificial Intelligence (AI) to enhance procedural outcomes, supported by favorable U.S. reimbursement policies. However, Intuitive Surgical faces intensifying competition from major players like Medtronic and Johnson & Johnson, which could challenge its long-term market share. Additionally, the firm contends with risks related to pricing pressures and potential regulatory delays for its next-generation technologies. Despite these headwinds, its robust ecosystem and technological lead remain central to its growth narrative in the medical technology sector.